Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its Q3 earnings later this week. Analysts are predicting strong growth driven by the continued success of Lilly's blockbuster drugs, particularly recent launches. However, there are also concerns about potential pressures from generic competitio